Donor-Derived Cell-Free DNA in Solid Organ Transplantation: An Evidence-Based Review
New Trends in Medicine Sciences · 30.06.2026 · 7 (2) · 64-71
DOI: 10.56766/ntms.1852728 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Trends in Medicine Sciences, online erschienen am 30.06.2026. Verfasst von Mahmut Aktğrk und 3 weiteren Autor:innen. Die Arbeit nennt 61 Literaturangaben.
Abstract (Originalsprache)
Donor-derived cell-free DNA (dd-cfDNA) refers to DNA fragments originating from the transplanted organ tissue that are detected in the recipient's circulation as products of cellular degradation. In recent years, dd-cfDNA has emerged as a compelling biomarker for immune monitoring and early diagnosis of rejection in solid organ transplantation—particularly in kidney, heart, lung, and liver transplants—due to its potential to provide earlier and more sensitive signals compared to conventional biomarkers. This review aims to address the biological foundations of dd-cfDNA, its measurement methodologies, organ-specific experimental and clinical data, as well as its current limitations and future perspectives.
Zitieren
APA
Aktğrk, M., Balkan, E., Altundaş, N., & Kızılkaya, M. (2026). Donor-Derived Cell-Free DNA in Solid Organ Transplantation: An Evidence-Based Review. New Trends in Medicine Sciences, 7(2), 64-71. https://doi.org/10.56766/ntms.1852728
Vancouver
Aktğrk M, Balkan E, Altundaş N, Kızılkaya M. Donor-Derived Cell-Free DNA in Solid Organ Transplantation: An Evidence-Based Review. New Trends in Medicine Sciences. 2026;7(2):64-71. doi:10.56766/ntms.1852728
BibTeX
@article{Aktrk2026,
author = {Aktğrk, Mahmut and Balkan, Eda and Altundaş, Necip and Kızılkaya, Murat},
title = {Donor-Derived Cell-Free DNA in Solid Organ Transplantation: An Evidence-Based Review},
journal = {New Trends in Medicine Sciences},
year = {2026},
volume = {7},
number = {2},
pages = {64--71},
doi = {10.56766/ntms.1852728}
}
EUVIMED